The core principle of BETMAT’s Kinetic Chromogenic LAL Assay is based on the specific enzymatic cascade triggered by the interaction between Limulus Amebocyte Lysate (LAL) and bacterial ...
-Presentations will include latest data from Factor's IL12-expressing iMacrophages for treating solid tumors (FACT-112), as ...
An ELRIG webinar has explored how cell-based screening supports drug discovery, from early target validation to advanced ...
Researchers at the National Institutes for Quantum Science and Technology (QST), Japan, and The University of Tokyo, Japan, ...
Explore luminescence screening assays for drug discovery, including luciferase and ATP assays. Learn the principles, formats, advantages, and limitations.
A biology first approach to drug discovery is uncovering stress linked vulnerabilities in cancer. Soley Therapeutics explains how whole-cell stress sensing revealed CKAP2 as a target and helped ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results